Salus Discovery is a pioneer in bioassays, diagnostics, sample preparation, and biomedical engineering, striving to drive innovation through groundbreaking research and product development. Since its establishment in 2013, the company has carved a niche for itself in the Biotechnology and Life Sciences sectors, with its headquarters located in the United States. Salus Discovery specializes in various domains including exclusion-based sample preparation, the EXTRACTMAN system, microfluidics, molecular biology, cell culture, and microscopy, with a strong emphasis on research and development and product development. Notably, the company's recent investment details and investors are currently undisclosed, marking an area of potential interest for venture capital to explore and engage with Salus Discovery's innovative endeavors.
There is no investment information
No recent news or press coverage available for Salus Discovery.